282 related articles for article (PubMed ID: 25420938)
21. MIR155 Regulation of Ubiquilin1 and Ubiquilin2: Implications in Cellular Protection and Tumorigenesis.
Yadav S; Singh N; Shah PP; Rowbotham DA; Malik D; Srivastav A; Shankar J; Lam WL; Lockwood WW; Beverly LJ
Neoplasia; 2017 Apr; 19(4):321-332. PubMed ID: 28315615
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1.
Liang Y; Zhao Q; Fan L; Zhang Z; Tan B; Liu Y; Li Y
Biomed Pharmacother; 2015 Oct; 75():137-41. PubMed ID: 26320367
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.
Kim SJ; Shin JY; Lee KD; Bae YK; Sung KW; Nam SJ; Chun KH
Breast Cancer Res; 2012 Jan; 14(1):R14. PubMed ID: 22251626
[TBL] [Abstract][Full Text] [Related]
24. Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype.
van der Veer EP; de Bruin RG; Kraaijeveld AO; de Vries MR; Bot I; Pera T; Segers FM; Trompet S; van Gils JM; Roeten MK; Beckers CM; van Santbrink PJ; Janssen A; van Solingen C; Swildens J; de Boer HC; Peters EA; Bijkerk R; Rousch M; Doop M; Kuiper J; Schalij MJ; van der Wal AC; Richard S; van Berkel TJ; Pickering JG; Hiemstra PS; Goumans MJ; Rabelink TJ; de Vries AA; Quax PH; Jukema JW; Biessen EA; van Zonneveld AJ
Circ Res; 2013 Oct; 113(9):1065-75. PubMed ID: 23963726
[TBL] [Abstract][Full Text] [Related]
25. IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2.
Mongroo PS; Noubissi FK; Cuatrecasas M; Kalabis J; King CE; Johnstone CN; Bowser MJ; Castells A; Spiegelman VS; Rustgi AK
Cancer Res; 2011 Mar; 71(6):2172-82. PubMed ID: 21252116
[TBL] [Abstract][Full Text] [Related]
26. Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328.
Paduano F; Dattilo V; Narciso D; Bilotta A; Gaudio E; Menniti M; Agosti V; Palmieri C; Perrotti N; Fusco A; Trapasso F; Iuliano R
FEBS J; 2013 Jan; 280(2):401-12. PubMed ID: 22564856
[TBL] [Abstract][Full Text] [Related]
27. Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.
Brewster BL; Rossiello F; French JD; Edwards SL; Wong M; Wronski A; Whiley P; Waddell N; Chen X; Bove B; ; Hopper JL; John EM; Andrulis I; Daly M; Volorio S; Bernard L; Peissel B; Manoukian S; Barile M; Pizzamiglio S; Verderio P; Spurdle AB; Radice P; Godwin AK; Southey MC; Brown MA; Peterlongo P
Hum Mutat; 2012 Dec; 33(12):1665-75. PubMed ID: 22753153
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis.
Bian Y; Wang L; Lu H; Yang G; Zhang Z; Fu H; Lu X; Wei M; Sun J; Zhao Q; Dong G; Lu Z
Biochem Biophys Res Commun; 2012 May; 422(1):187-93. PubMed ID: 22569043
[TBL] [Abstract][Full Text] [Related]
29. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
[TBL] [Abstract][Full Text] [Related]
30. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
[TBL] [Abstract][Full Text] [Related]
31. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.
Li D; Peng X; Yan D; Tang H; Huang F; Yang Y; Peng Z
Ann Surg Oncol; 2011 Jul; 18(7):2074-83. PubMed ID: 21442350
[TBL] [Abstract][Full Text] [Related]
32. miR‑4262 inhibits colon cancer cell proliferation via targeting of GALNT4.
Qu JJ; Qu XY; Zhou DZ
Mol Med Rep; 2017 Oct; 16(4):3731-3736. PubMed ID: 28731150
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7.
Li Q; Zou C; Zou C; Han Z; Xiao H; Wei H; Wang W; Zhang L; Zhang X; Tang Q; Zhang C; Tao J; Wang X; Gao X
Cancer Lett; 2013 Jul; 335(1):168-74. PubMed ID: 23435373
[TBL] [Abstract][Full Text] [Related]
34. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of microRNA‑155 by preoperative administration of valproic acid prevents postoperative seizures by upregulating SCN1A.
Zhang Z; Wang Z; Zhang B; Liu Y
Mol Med Rep; 2018 Jan; 17(1):1375-1381. PubMed ID: 29115566
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-433 Represses Proliferation and Invasion of Colon Cancer Cells by Targeting Homeobox A1.
Li H; Li J; Yang T; Lin S; Li H
Oncol Res; 2018 Mar; 26(2):315-322. PubMed ID: 29137689
[TBL] [Abstract][Full Text] [Related]
37. [miR-216b suppresses cell proliferation and invasion by targeting PKCα in nasopharyngeal carcinoma cells].
Deng M; Liu JF; Gu YX; Zheng GP; He ZM
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):645-50. PubMed ID: 24332049
[TBL] [Abstract][Full Text] [Related]
38. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-145 regulates the proliferation, migration and invasion of human primary colon adenocarcinoma cells by targeting MAPK1.
Yang Y; Li XJ; Li P; Guo XT
Int J Mol Med; 2018 Dec; 42(6):3171-3180. PubMed ID: 30272312
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-185 suppresses growth and invasion of colon cancer cells through inhibition of the hypoxia‑inducible factor-2α pathway in vitro and in vivo.
Lu ZJ; Lu LG; Tao KZ; Chen DF; Xia Q; Weng JJ; Zhu F; Wang XP; Zheng P
Mol Med Rep; 2014 Nov; 10(5):2401-8. PubMed ID: 25216407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
